Skip to main content
Year archive

Telix Pharmaceuticals Ltd — 2021 filings

All 90 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2021, sourced directly from the official regulator.

90 Filings
2021 Period
2021 filings (90)
Filing Released Lang
Targeted Alpha Therapy for Bladder Cancer 1st patient dosed 3 pages 217.7KB
Regulatory Filings
2021-12-20 English
Notification of cessation of securities - TLX 5 pages 27.2KB
Regulatory Filings
2021-12-20 English
FDA Approves Telix Prostate Cancer Imaging Product Illuccix 3 pages 225.2KB
Regulatory Filings
2021-12-19 English
Illuccix EU Regulatory Submission Progress Update 2 pages 205.2KB
Regulatory Filings
2021-12-09 English
NUCLIBER - Distribution Agreement for Illuccix in Spain 2 pages 210.3KB
Regulatory Filings
2021-12-07 English
Illuccix Granted Use Authorisation in Brazil 2 pages 210.5KB
Regulatory Filings
2021-11-30 English
Investor Presentation - November 2021 38 pages 6.6MB
Regulatory Filings
2021-11-15 English
Australian TGA Approves Illuccix for Prostate Cancer Imaging 2 pages 210.6KB
Regulatory Filings
2021-11-01 English
Release of Shares from Voluntary Escrow 1 page 193.
Regulatory Filings
2021-10-20 English
Activities Report and App 4C - September 2021 quarter 12 pages 1.4MB
Regulatory Filings
2021-10-20 English
IPAX-1 Presentation at Congress of Neurological Surgeons 3 pages 271.5KB
Regulatory Filings
2021-10-19 English
Application for quotation of securities - TLX 8 pages 32.9KB
Regulatory Filings
2021-09-28 English
Appendix 3Y - Change of Directors Interest Notice - Nelson 3 pages 214.3KB
Regulatory Filings
2021-09-28 English
Appendix 3Y - Change of Directors Interest Notice - McCann 3 pages 222.0KB
Regulatory Filings
2021-09-28 English
Cleansing Notice under S708A Corporations Act 1 pag
Regulatory Filings
2021-09-28 English
$12.1M R&D Tax Refund, Overseas Finding Increased to $139M 2 pages 201.9KB
Regulatory Filings
2021-09-27 English
FDA Extends New Drug Application Review Period for Illuccix 2 pages 211.2KB
Regulatory Filings
2021-09-22 English
Telix Supporting Amgen PSMA-Targeting Therapy Trial 2 pages 199.4KB
Regulatory Filings
2021-09-14 English
FDA Approves Phase II Kidney Cancer Therapy Study 2 pages 169.8KB
Regulatory Filings
2021-09-13 English
NCCN Guidelines updated to include PSMA-PET Imaging 2 pages 205.4KB
Regulatory Filings
2021-09-13 English
Telix and Radius sign Distribution Agreement for Italy 2 pages 210.9KB
Regulatory Filings
2021-09-12 English
Japanese Prostate Cancer Imaging Study Completes Enrolment 2 pages 203.9KB
Regulatory Filings
2021-09-08 English
Change in substantial holding 2 pages 176.9KB
Regulatory Filings
2021-08-31 English
Collaboration with Lightpoint Medical on Radioguided Surgery 2 pages 214.4KB
Regulatory Filings
2021-08-22 English
GenesisCare Collaboration Expands Prostate Cancer Activity 2 pages 196.2KB
Regulatory Filings
2021-08-18 English
App 4D and Report for Half-Year Ended 30 June 2021 33 pages 4.3MB
Regulatory Filings
2021-08-18 English
Results Presentation and Shareholder Update 1H 2021 31 pages 8.9MB
Regulatory Filings
2021-08-18 English
Two studies explore TLX assets in Breast Cancer Theranostics 3 pages 234.4KB
Regulatory Filings
2021-08-17 English
Telix and Merck pan-cancer clinical collaboration 2 pages 201.6KB
Regulatory Filings
2021-08-17 English
TLX66 in Phase II Academic Study of Pediatric Leukemia 2 pages 205.7KB
Regulatory Filings
2021-08-16 English
Telix H1 2021 Results and Company Update Conference Call 1
Regulatory Filings
2021-08-10 English
1st Patient Dosed in CUPID study of TLX592 3 pages 227.2KB
Regulatory Filings
2021-08-04 English
Telix Seneffe Production Facility - Progress Update 2 pages 202.8KB
Regulatory Filings
2021-07-29 English
Notification regarding unquoted securities - TLX 7 pages 30.8KB
Regulatory Filings
2021-07-21 English
Notification regarding unquoted securities - TLX 7 pages 30.8KB
Regulatory Filings
2021-07-21 English
Notification of cessation of securities - TLX 4 pages 24.5KB
Regulatory Filings
2021-07-21 English
Notification of cessation of securities - TLX 4 pages 24.5KB
Regulatory Filings
2021-07-21 English
Notification of cessation of securities - TLX 4 pages 24.5KB
Regulatory Filings
2021-07-21 English
Notification of cessation of securities - TLX 4 pages 24.5KB
Regulatory Filings
2021-07-21 English
Notification of cessation of securities - TLX 4 pages 24.5KB
Regulatory Filings
2021-07-21 English
App 4C and Activities Report for June 2021 Quarter 11 pages 1.4MB
Regulatory Filings
2021-07-21 English
ZIRCON Phase 3 Renal Cancer Imaging Study - Progress Update 3 pages 216.0KB
Regulatory Filings
2021-07-19 English
Ky Williamson to lead corporate communications and IR 2 pages 198.7KB
Regulatory Filings
2021-07-11 English
Change in substantial holding 3 pages 185.5KB
Regulatory Filings
2021-07-04 English
Cleansing Notice - issue of shares upon exercise of options 1
Regulatory Filings
2021-07-01 English
Application for quotation of securities - TLX 6 pages 28.0KB
Regulatory Filings
2021-07-01 English
1st patient dosed in TLX250-CDx study in Bladder Cancer 2 pages 211.5KB
Regulatory Filings
2021-06-22 English
TLX101 for Glioblastoma Therapy - Clinical Trial Update 2 pages 201.1KB
Regulatory Filings
2021-06-20 English
Update on FDA New Drug Application Review for Illuccix 2 pages 201.0KB
Regulatory Filings
2021-06-16 English
Telix and ATS $1.56M Eurostars Grant for Alpha Therapy 2 pages 208.4KB
Regulatory Filings
2021-06-06 English
US Co-Promotion with EZAG for Prostate Cancer Imaging 2 pages 205.4KB
Regulatory Filings
2021-06-02 English
Presentation to Jefferies Healthcare Conference 25 pages 18.1MB
Regulatory Filings
2021-06-01 English
1st Patient Dosed in Japanese Prostate Cancer Imaging Study 2 pages 200.6KB
Regulatory Filings
2021-05-24 English
TLX66 Meets Study Objectives in Patients with AL Amyloidosis 2 pages 214.6KB
Regulatory Filings
2021-05-24 English
Shareholder Update - TRALA Trial of TLX66 in SALA 10 pages 4.0MB
Regulatory Filings
2021-05-24 English
German Distribution Agreement with Eckert and Ziegler 2 pages 210.6KB
Regulatory Filings
2021-05-17 English
Chairmans Address to AGM 4 pages 223.0KB
Regulatory Filings
2021-05-11 English
CEOs Address to AGM 11 pages 937.4KB
Regulatory Filings
2021-05-11 English
AGM Results of Meeting 2 pages 255.1KB
Regulatory Filings
2021-05-11 English
App 3Y - issue of CEO options following Shareholder approval 3 pages 218.6KB
Regulatory Filings
2021-05-11 English
Phase III Prostate Cancer Therapy Clinical Trial Commences 2 pages 218.3KB
Regulatory Filings
2021-05-09 English
Telix Appoints Mr Richard Valeix as EMEA President 2 pages 203.2KB
Regulatory Filings
2021-05-02 English
Executive Leadership Appointments and Establishment of APAC 2 pages 204.5KB
Regulatory Filings
2021-05-02 English
Manufacturing Agreement with Global Medical Solutions 2 pages 207.0KB
Regulatory Filings
2021-04-26 English
Activities Report and App 4C for quarter ended 31 March 2021 10 pages 1.3MB
Regulatory Filings
2021-04-21 English
Japanese Renal Cancer Imaging Trial Meets Study Objectives 2 pages 209.7KB
Regulatory Filings
2021-04-20 English
Launch of International NOBLE Registry for SPECT Imaging 2 pages 213.7KB
Regulatory Filings
2021-04-18 English
TGA commences priority evaluation process for Illuccix 2 pages 212.3KB
Regulatory Filings
2021-04-13 English
AGM Notice of Meeting and Explanatory Memorandum 20 pages 398.5KB
Regulatory Filings
2021-04-11 English
Agreement with GRAM for commercial manufacture of Illucix 2 pages 205.0KB
Regulatory Filings
2021-03-30 English
App 2A - quotation of shares issued upon exercise of options 15 pages 220.1KB
Regulatory Filings
2021-03-25 English
Cleansing Notice - shares issued upon exercise of options 1
Regulatory Filings
2021-03-25 English
Global Agreements with ITM for Lutetium-177 Supply 2 pages 211.8KB
Regulatory Filings
2021-03-17 English
App 2A - quotation of shares on exercise of options 15 pages 219.0KB
Regulatory Filings
2021-03-08 English
Cleansing Notice - issue of shares upon exercise of options 1
Regulatory Filings
2021-03-08 English
App 2A - quotation of shares on exercise of options 15 pages 219.2KB
Regulatory Filings
2021-03-01 English
Cleansing Notice - issue of shares upon exercise of options 1
Regulatory Filings
2021-03-01 English
Shareholder update - year ended 31 December 2020 34 pages 2.7MB
Regulatory Filings
2021-02-25 English
Appendix 4G - key to governance disclosures 11 pages 226.1KB
Regulatory Filings
2021-02-25 English
Corporate Governance Statement year ended 31 December 2020 10 pages 488.8KB
Regulatory Filings
2021-02-25 English
Appendix 4E - Results for announcement to the market 1
Regulatory Filings
2021-02-25 English
2020 Annual Report 104 pages 3.9MB
Regulatory Filings
2021-02-25 English
PMDA clearance to commence Prostate Cancer Imaging Study 2 pages 207.7KB
Regulatory Filings
2021-02-21 English
Notification of Conference Call for FY2020 Results 1
Regulatory Filings
2021-02-15 English
Czech Republic Grants National Authorisation for TLX591 Kit 2 pages 211.3KB
Regulatory Filings
2021-02-15 English
Collaboration with Heidelberg University Hospital 2 pages 202.4KB
Regulatory Filings
2021-02-09 English
Telix Pursues Direct Benelux Product Distribution 2 pages 211.8KB
Regulatory Filings
2021-02-07 English
Appendix 4C and Activities Report for December 2020 Quarter 10 pages 1.4MB
Regulatory Filings
2021-01-28 English
Appendix 3G - issue of unlisted share options 13 pages 226.1KB
Regulatory Filings
2021-01-28 English
First US patients dosed in Ph III ZIRCON trial 2 pages 226.4KB
Regulatory Filings
2021-01-24 English